Eventide Asset Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $1.87M | Hold |
|
|||||
|
2022
Q3 | $4.01M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $1.84M | Sell |
|
|||||
|
2021
Q3 | $11.6M | Hold |
|
|||||
|
2021
Q2 | $15.9M | Sell |
|
|||||
|
2021
Q1 | $35.3M | Sell |
|
|||||
|
2020
Q4 | $31.9M | Hold |
|
|||||
|
2020
Q3 | $21.2M | Hold |
|
|||||
|
2020
Q2 | $20.3M | Hold |
|
|||||
|
2020
Q1 | $12.9M | Hold |
|
|||||
|
2019
Q4 | $29.9M | Hold |
|
|||||
|
2019
Q3 | $19.5M | Buy |
|
|||||
|
2019
Q2 | $33.2M | Buy |
|
|||||
|
2019
Q1 | $25.8M | Hold |
|
|||||
|
2018
Q4 | $17.8M | Hold |
|
|||||
|
2018
Q3 | $19.9M | Hold |
|
|||||
|
2018
Q2 | $7.31M | Hold |
|
|||||
|
2018
Q1 | $8.53M | Buy |
|
|||||
|
2017
Q4 | $6.91M | Buy |
|
|||||
|
2017
Q3 | $2.64M | Buy |
|
|||||
|
2017
Q2 | $1.37M | Buy |
|
|||||
|
2017
Q1 | $766K | Buy |
|